🧾 What This Document Is

This is a press release filed with the SEC as a 6-K report. It’s a formal announcement to investors that iTonic Holdings Ltd has received a critical extension from the Nasdaq stock exchange. Think of it as a " lifeline" notice.

📢 The Big News: A Compliance Extension

Nasdaq has granted iTonic an additional 180-day extension, until October 19, 2026, to get its stock price back in order. The company’s initial 180-day period to fix this problem just expired on April 20, 2026. This new window is their second chance.

👉 Why it matters: Without this extension, the company faced immediate delisting (removal) from the Nasdaq stock market, which would make it much harder for investors to trade shares and could hurt the company's credibility.

⚖️ The Rule They Must Follow: Minimum Bid Price

The specific rule iTonic must meet is Nasdaq's "Minimum Bid Price Rule." This is a simple regulation that requires a company's stock to trade at or above $1.00 per share. iTonic's stock has been trading below that threshold, triggering this compliance process.

🏢 Who is iTonic Holdings Ltd?

In simple terms, iTonic is a healthcare technology company based in Beijing, China. It was founded in 1998 and specializes in software for brachytherapy—a precise form of radiation therapy used to treat cancer by placing radioactive sources directly inside or next to a tumor.

👉 Its flagship product is a Treatment Planning System that helps doctors plan and deliver this complex cancer treatment safely and effectively.

🔮 What Happens Next? The Timeline

The clock is ticking. iTonic has until October 19, 2026, to get its stock price to close at or above $1.00 for a sustained period. If they succeed, they regain full compliance.

⚠️ If they fail by that date, Nasdaq will send a delisting notice. However, the company can then appeal and request a hearing with a Nasdaq Panel to argue its case.

⚖️ Big Picture: Strengths & Risks

👍 Strength: The company is operating in the important and growing field of cancer treatment technology. Securing this extension gives it crucial time and stability to focus on its business operations without the immediate threat of delisting.

⚠️ Risks: The core problem—the low stock price—remains unresolved. This situation signals that investors currently have low confidence in the company. Delisting remains a real threat in October, which would significantly reduce stock liquidity and visibility.

🧠 The Analogy

Imagine a student who is failing a class (stock price below $1.00). The teacher (Nasdaq) gave them a first chance (initial 180 days) to bring their grade up. They didn't. Now, the teacher is giving them a final, second-semester extension (another 180 days) to pass the final exam. If they still fail, they'll be held back (delisted), though they can plead their case to the school principal (Nasdaq Panel).

🧩 Final Takeaway

iTonic Holdings Ltd has bought itself time, but its future on the Nasdaq exchange is not secure. The next six months are critical for the company to improve its stock price, or it faces the serious consequence of being delisted. This filing is a warning flare to investors about the ongoing risk.

Contact Information: iTonic Holdings Ltd Investor Relations Email: [email protected]

Lambert by LLYC Jackson Lin Phone: +1-646-717-4593 Email: [email protected]